Moderately elevated ambient temperature is associated with increased mortality in patients undergoing dialysis, according to ...

Illuccix has gained significant market share due to changes in clinical practice and successful distribution. The company requires minimal capital and is expected to generate very high returns as it ...

At AUA 2025, experts will present on novel bladder cancer therapies, advanced renal cell carcinoma comparisons, frailty in ...

Support is pouring in for a longtime Victor firefighter and father of two after a recent cancer diagnosis disrupted his life ...

Sunshine Biopharma, Inc.'s stock rose over 3% on Monday, lifting retail investor sentiment, after the company said its ...

Sunshine Biopharma (SBFM) announced that its wholly owned Canadian subsidiary, Nora Pharma, has launched Everolimus in the Canadian generic ...

William Blair initiated coverage of Xencor (XNCR) with an Outperform rating. The firm believes the biopharmaceutical industry is entering a ...

There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...

During a live event, Martin Voss, MD, reviewed the trials of lenvatinib plus pembrolizumab, cabozantinib plus nivolumab, and ...

“Our CB-SCs can target different compartments of the immune system, educating and correcting their dysfunctions at a fundamental level,” says Dr. Zhao. “This therapy has the potential to revolutionize ...

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...